BioSpace News Archive

Semeon Analytics, an ATW Tech Inc. company, and Adexflow international are joining forces to collaborate, beginning in the second quarter of 2021, on a series of service mandates and joint offers concerning the management of critical data and advanced text analytics in the sectors of military, shipbuilding and engineering infrastructure.

Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that studies conducted with its BMB proprietary 5-HT2C agonists show robust efficacy in rodent models of opioid self-administration as a treatment for opioid use disorder (“OUD”).

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced biomarker results from its Phase 2 double-blind, placebo-controlled clinical trial of its lead therapeutic candidate, ATYR1923, in hospitalized COVID-19 patients with severe respiratory complications receiving standard of care, including remdesivir and/or dexamethasone,

Biotech Acquisition Company (NASDAQ: BIOTU) (the “Company”) announced that, commencing March 18, 2021 , holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (“Class A Ordinary Shares”) and warrants included in the units. No fractional warrants will be issue